Driving and Funding Innovation in Biotech with Orange Grove Bio CEO Marc Appel
In this week’s episode, Mark and Marc discuss innovation in the life sciences industry, including the recent launch of Orange Grove’s portfolio company, Asalyxa Bio. Topics include: Remdesivir and Marc’s view on this experimental medicine for combatting effects of COVID-19 Why Marc decided to focus his professional life on funding innovations in health care…
Read More